Home
>
US Stocks
>
Ocugen Inc
Ocugen Inc
OCGN

Ocugen Inc (OCGN)

$8.3211.68%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
$7.92
Today Low/High
$7.76 / $8.38
52 Week Low/High
$0.25 / $18.77
Market Cap
$1.43B

Company Details

Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. Its breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug - "one to many" and its novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. The Company is co-developing Bharat Biotech's COVAXIN™ vaccine candidate for COVID-19 in the U.S. market.
Organisation
Ocugen Inc
Headquaters
Malvern, Pennsylvania, US
Employees
15
Industry
Health Technology
CEO
Shankar Musunuri

Discover more

Frequently Asked Questions

What is Ocugen Inc (OCGN) share price today?

Can Indians buy Ocugen Inc (OCGN) shares?

How can I buy Ocugen Inc (OCGN) shares from India?

Can Fractional shares of Ocugen Inc (OCGN) be purchased?

What are the documents required to start investing in Ocugen Inc (OCGN) stocks?

We are a SEBI registered investement advisor